The estimated annual cost of a 7 mg once-daily dose is approximately US$186 per patient, while the 14 mg once-daily dose is estimated at US$344 per patient per year
Improved Metabolic Health: Lowered blood sugar levels and improved insulin sensitivity
This period is referred to as a metabolic set point, which is when someones weight aligns with their genetics and environment
The Care360 model may include ongoing provider oversight, clinical follow-up, behavioral support, patient education, nutrition guidance, metabolic health tracking, and continuous care coordination throughout the treatment journey
Cardiovascular disease (CVD) is the main cause of death and disability among people with type 2 diabetes.[2] Adults with type 2 diabetes are two to four times more likely to develop CVD than adults without diabetes.[3] The FDA's decision on semaglutide is based on results from the SUSTAIN 6 cardiovascular outcomes trial (CVOT), which examined the cardiovascular safety of adding Ozempic or placebo to standard-of-care in adults with type 2 diabetes and established cardiovascular disease
Activation of these receptors produces several important physiological effects